Who is sponsoring STEMPAD?

STEMPAD is sponsored by Washington University School of Medicine.

What condition does STEMPAD study?

STEMPAD studies Peripheral Vascular Diseases.

What drugs are being tested in STEMPAD?

Interventions: G-CSF, Placebo, Aspirin, Clopidogrel.

What is the status of STEMPAD?

STEMPAD is currently COMPLETED.

Last reviewed 2015-03-30 · How we verify

Pilot Study of Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease (STEMPAD Trial)

NCT00797056 EARLY_PHASE1 COMPLETED

This study is designed to test the use of G-CSF in peripheral vascular disease. The investigators hypothesize that mobilization of angiogenic cells into the blood by granulocyte colony stimulating factor (G-CSF) may stimulate the formation of new blood vessels and result in a sustained improvement in blood flow in patients with severe peripheral arterial disease.

Details

Lead sponsor	Washington University School of Medicine
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	32
Start date	2008-04
Completion	2012-04

Conditions

Peripheral Vascular Diseases

Interventions

G-CSF
Placebo
Aspirin
Clopidogrel

Primary outcomes

Major limb amputation rate as defined by amputations of the limb that are transmetarsal and higher — 1 year

Countries

United States